Trial in progress: A phase 2 study of intratumor pil-12 plus electroporation in combination with intravenous pembrolizumab in patients with stage III/IV mealanoma progressing on either pembrolizumab or nivolumab treatment (PISCES)
| Autor: | Chris Twitty, John M. Kirkwood, Tom Van Hagen, Phillip Parente, Arkadiusz Z. Dudek, Gregory A. Daniels, Anne Poh Long, Igor Puzanov, Sharron Gargosky, Andrew Haydon, Robert H.I. Andtbacka, Sajeve Samuel Thomas, Victoria Atkinson |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty business.industry Electroporation medicine.medical_treatment Phases of clinical research Pembrolizumab Immunotherapy Internal medicine Medicine In patient sense organs Stage (cooking) Nivolumab skin and connective tissue diseases business Advanced melanoma |
| Zdroj: | Journal of Clinical Oncology. 36:TPS9601-TPS9601 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2018.36.15_suppl.tps9601 |
| Popis: | TPS9601Background: Immunotherapy and targeted therapies have significantly changed the treatment landscape for advanced melanoma over the past few years. However, despite the addition of these new ... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|